ID 1433Z_BOVIN Reviewed; 245 AA. AC P63103; P29213; P29312; Q3ZCF9; DT 13-SEP-2004, integrated into UniProtKB/Swiss-Prot. DT 13-SEP-2004, sequence version 1. DT 02-SEP-2026, entry version 174. DE RecName: Full=14-3-3 protein zeta/delta; DE AltName: Full=Factor activating exoenzyme S; DE Short=FAS; DE AltName: Full=Protein kinase C inhibitor protein 1; DE Short=KCIP-1; GN Name=YWHAZ; OS Bos taurus (Bovine). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae; OC Bovinae; Bos. OX NCBI_TaxID=9913; RN [1] RP PROTEIN SEQUENCE. RC TISSUE=Brain; RX PubMed=1499718; DOI=10.1016/0014-5793(92)81257-m; RA Isobe T., Hiyane Y., Ichimura T., Okuyama T., Takahashi N., Nakajo S., RA Nakaya K.; RT "Activation of protein kinase C by the 14-3-3 proteins homologous with Exo1 RT protein that stimulates calcium-dependent exocytosis."; RL FEBS Lett. 308:121-124(1992). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 104-115; 140-157 AND RP 194-212. RC TISSUE=Brain; RX PubMed=8460141; DOI=10.1073/pnas.90.6.2320; RA Fu H., Coburn J., Collier R.J.; RT "The eukaryotic host factor that activates exoenzyme S of Pseudomonas RT aeruginosa is a member of the 14-3-3 protein family."; RL Proc. Natl. Acad. Sci. U.S.A. 90:2320-2324(1993). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=Crossbred X Angus; TISSUE=Ileum; RG NIH - Mammalian Gene Collection (MGC) project; RL Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases. RN [4] RP FUNCTION. RX PubMed=7931346; DOI=10.1046/j.1471-4159.1994.63051908.x; RA Tanji M., Horwitz R., Rosenfeld G., Waymire J.C.; RT "Activation of protein kinase C by purified bovine brain 14-3-3: comparison RT with tyrosine hydroxylase activation."; RL J. Neurochem. 63:1908-1916(1994). RN [5] RP X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS). RX PubMed=7603574; DOI=10.1038/376191a0; RA Liu D., Blenkowska J., Petosa C., Collier R.J., Fu H., Liddington R.; RT "Crystal structure of the zeta isoform of the 14-3-3 protein."; RL Nature 376:191-194(1995). RN [6] RP X-RAY CRYSTALLOGRAPHY (3.35 ANGSTROMS) IN COMPLEX WITH PHOSPHORYLATED RAF1, RP INTERACTION WITH PHOSPHOSERINE PEPTIDE, AND SUBUNIT. RX PubMed=9632691; DOI=10.1074/jbc.273.26.16305; RA Petosa C., Masters S.C., Bankston L.A., Pohl J., Wang B., Fu H., RA Liddington R.C.; RT "14-3-3zeta binds a phosphorylated Raf peptide and an unphosphorylated RT peptide via its conserved amphipathic groove."; RL J. Biol. Chem. 273:16305-16310(1998). RN [7] RP X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) IN COMPLEX WITH PHOSPHORYLATED ITGB2, RP AND INTERACTION WITH PHOSPHORYLATED ITGB2. RX PubMed=18550856; DOI=10.1182/blood-2007-12-127795; RA Takala H., Nurminen E., Nurmi S.M., Aatonen M., Strandin T., Takatalo M., RA Kiema T., Gahmberg C.G., Ylaenne J., Fagerholm S.C.; RT "Beta2 integrin phosphorylation on Thr758 acts as a molecular switch to RT regulate 14-3-3 and filamin binding."; RL Blood 112:1853-1862(2008). CC -!- FUNCTION: Adapter protein implicated in the regulation of a large CC spectrum of both general and specialized signaling pathways CC (PubMed:7931346). Binds to a large number of partners, usually by CC recognition of a phosphoserine or phosphothreonine motif CC (PubMed:7931346). Binding generally results in the modulation of the CC activity of the binding partner (PubMed:7931346). Promotes cytosolic CC retention and inactivation of TFEB transcription factor by binding to CC phosphorylated TFEB. Induces ARHGEF7 activity on RAC1 as well as CC lamellipodia and membrane ruffle formation (By similarity). In neurons, CC regulates spine maturation through the modulation of ARHGEF7 activity CC (By similarity). {ECO:0000250|UniProtKB:O55043, CC ECO:0000250|UniProtKB:P63104, ECO:0000269|PubMed:7931346}. CC -!- SUBUNIT: Homodimer. Heterodimerizes with YWHAE (By similarity). CC Homo- and heterodimerization is inhibited by phosphorylation on Ser-58 CC (By similarity). Interacts with FOXO4, NOXA1, SSH1 ARHGEF2, CDK16 and CC BSPRY. Interacts with WEE1 (C-terminal). Interacts with MLF1 CC (phosphorylated form); the interaction retains it in the cytoplasm. CC Interacts with BAX; the interaction occurs in the cytoplasm. Under CC stress conditions, MAPK8-mediated phosphorylation releases BAX to CC mitochondria. Interacts with TP53; the interaction enhances p53 CC transcriptional activity. The Ser-58 phosphorylated form inhibits this CC interaction and p53 transcriptional activity. Interacts with ABL1 CC (phosphorylated form); the interaction retains ABL1 in the cytoplasm. CC Interacts with PKA-phosphorylated AANAT; the interaction modulates CC AANAT enzymatic activity by increasing affinity for arylalkylamines and CC acetyl-CoA and protecting the enzyme from dephosphorylation and CC proteasomal degradation. It may also prevent thiol-dependent CC inactivation (By similarity). Interacts with AKT1; the interaction CC phosphorylates YWHAZ and modulates dimerization (By similarity). CC Interacts with GAB2. Interacts with BCL2L11, SAMSN1 and TLK2 (By CC similarity). Interacts with phosphorylated RAF1; the interaction is CC inhibited when YWHAZ is phosphorylated on Thr-232. Interacts with Thr- CC phosphorylated ITGB2. Interacts with the 'Thr-369' phosphorylated form CC of DAPK2 (By similarity). Interacts with PI4KB, TBC1D22A and TBC1D22B CC (By similarity). Interacts with ZFP36L1 (via phosphorylated form); this CC interaction occurs in a p38 MAPK- and AKT-signaling pathways (By CC similarity). Interacts with SLITRK1 (By similarity). Interacts with CC AK5, LDB1, MADD, MARK3, PDE1A and SMARCB1 (By similarity). Interacts CC with YWHAZ (By similarity). Interacts with MEFV (By similarity). CC Interacts with ADAM22 (via C-terminus) (By similarity). CC {ECO:0000250|UniProtKB:P63101, ECO:0000250|UniProtKB:P63104, CC ECO:0000250|UniProtKB:Q9ES28, ECO:0000269|PubMed:18550856, CC ECO:0000269|PubMed:9632691}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P63104}. CC Melanosome {ECO:0000250|UniProtKB:P63104}. Note=Located to stage I to CC stage IV melanosomes. {ECO:0000250|UniProtKB:P63104}. CC -!- PTM: The delta, brain-specific form differs from the zeta form in being CC phosphorylated. Phosphorylation on Ser-184 by MAPK8; promotes CC dissociation of BAX and translocation of BAX to mitochondria. CC Phosphorylation on Thr-232; inhibits binding of RAF1. Phosphorylated on CC Ser-58 by PKA and protein kinase C delta type catalytic subunit in a CC sphingosine-dependent fashion. Phosphorylation on Ser-58 by PKA; CC disrupts homodimerization and heterodimerization with YHAE and TP53. CC {ECO:0000250|UniProtKB:P63104}. CC -!- SIMILARITY: Belongs to the 14-3-3 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; L07955; AAA30514.1; -; mRNA. DR EMBL; BC102382; AAI02383.1; -; mRNA. DR PIR; A47389; A47389. DR PIR; S65013; S65013. DR RefSeq; NP_777239.1; NM_174814.2. DR RefSeq; XP_024857197.1; XM_025001429.2. DR RefSeq; XP_024857198.1; XM_025001430.2. DR PDB; 1A37; X-ray; 3.60 A; A/B=1-245. DR PDB; 1A38; X-ray; 3.35 A; A/B=1-245. DR PDB; 1A4O; X-ray; 2.80 A; A/B/C/D=1-245. DR PDB; 2V7D; X-ray; 2.50 A; A/B/C/D=1-245. DR AlphaFoldDB; P63103; -. DR BMRB; P63103; -. DR SMR; P63103; -. DR BioGRID; 160005; 5. DR CORUM; P63103; -. DR FunCoup; P63103; 3185. DR IntAct; P63103; 10. DR MINT; P63103; -. DR STRING; 9913.ENSBTAP00000000289; -. DR PaxDb; 9913-ENSBTAP00000000289; -. DR PeptideAtlas; P63103; -. DR Ensembl; ENSBTAT00000000289.7; ENSBTAP00000000289.4; ENSBTAG00000000236.7. DR Ensembl; ENSBTAT00085045106; ENSBTAP00085028139; ENSBTAG00085000367. DR Ensembl; ENSBTAT00090037085; ENSBTAP00090018937; ENSBTAG00090018372. DR GeneID; 287022; -. DR KEGG; bta:287022; -. DR CTD; 7534; -. DR VEuPathDB; HostDB:ENSBTAG00000000236; -. DR VGNC; VGNC:53885; YWHAZ. DR eggNOG; KOG0841; Eukaryota. DR GeneTree; ENSGT01090000260040; -. DR HOGENOM; CLU_058290_1_0_1; -. DR InParanoid; P63103; -. DR OMA; YDEMVNE; -. DR OrthoDB; 10260625at2759; -. DR Reactome; R-BTA-111447; Activation of BAD and translocation to mitochondria. DR Reactome; R-BTA-3769402; Deactivation of the beta-catenin transactivating complex. DR Reactome; R-BTA-392517; Rap1 signalling. DR Reactome; R-BTA-430116; GP1b-IX-V activation signalling. DR Reactome; R-BTA-450604; KSRP (KHSRP) binds and destabilizes mRNA. DR Reactome; R-BTA-512988; Interleukin-3, Interleukin-5 and GM-CSF signaling. DR Reactome; R-BTA-5625740; RHO GTPases activate PKNs. DR Reactome; R-BTA-5628897; TP53 Regulates Metabolic Genes. DR Reactome; R-BTA-75035; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex. DR Reactome; R-BTA-9013700; NOTCH4 Activation and Transmission of Signal to the Nucleus. DR Reactome; R-BTA-9614399; Regulation of localization of FOXO transcription factors. DR EvolutionaryTrace; P63103; -. DR PRO; PR:P63103; -. DR Proteomes; UP000009136; Chromosome 14. DR Bgee; ENSBTAG00000000236; Expressed in occipital lobe and 108 other cell types or tissues. DR GO; GO:0005737; C:cytoplasm; ISS:UniProtKB. DR GO; GO:0005829; C:cytosol; IEA:Ensembl. DR GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl. DR GO; GO:0098686; C:hippocampal mossy fiber to CA3 synapse; IEA:Ensembl. DR GO; GO:0042470; C:melanosome; ISS:UniProtKB. DR GO; GO:0005634; C:nucleus; IEA:Ensembl. DR GO; GO:0140297; F:DNA-binding transcription factor binding; IEA:Ensembl. DR GO; GO:0042802; F:identical protein binding; IEA:Ensembl. DR GO; GO:0050815; F:phosphoserine residue binding; ISS:UniProtKB. DR GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl. DR GO; GO:0019901; F:protein kinase binding; IEA:Ensembl. DR GO; GO:0019903; F:protein phosphatase binding; IEA:Ensembl. DR GO; GO:0140311; F:protein sequestering activity; ISS:UniProtKB. DR GO; GO:0044325; F:transmembrane transporter binding; IEA:Ensembl. DR GO; GO:0031625; F:ubiquitin protein ligase binding; IEA:Ensembl. DR GO; GO:0001525; P:angiogenesis; IEA:Ensembl. DR GO; GO:0042149; P:cellular response to glucose starvation; IEA:Ensembl. DR GO; GO:0051683; P:establishment of Golgi localization; IEA:Ensembl. DR GO; GO:0090168; P:Golgi reassembly; IEA:Ensembl. DR GO; GO:0008104; P:intracellular protein localization; IBA:GO_Central. DR GO; GO:0030324; P:lung development; IEA:Ensembl. DR GO; GO:0045824; P:negative regulation of innate immune response; IEA:Ensembl. DR GO; GO:1900181; P:negative regulation of protein localization to nucleus; IEA:Ensembl. DR GO; GO:1904262; P:negative regulation of TORC1 signaling; IEA:Ensembl. DR GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:Ensembl. DR GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB. DR GO; GO:0070372; P:regulation of ERK1 and ERK2 cascade; ISS:UniProtKB. DR GO; GO:0090128; P:regulation of synapse maturation; IEA:Ensembl. DR GO; GO:0003016; P:respiratory system process; IEA:Ensembl. DR GO; GO:0007165; P:signal transduction; ISS:UniProtKB. DR GO; GO:0008039; P:synaptic target recognition; IEA:Ensembl. DR GO; GO:0035148; P:tube formation; IEA:Ensembl. DR CDD; cd10022; 14-3-3_beta_zeta; 1. DR DisProt; DP04073; -. DR FunFam; 1.20.190.20:FF:000001; 14-3-3 gamma 1; 1. DR Gene3D; 1.20.190.20; 14-3-3 domain; 1. DR InterPro; IPR000308; 14-3-3. DR InterPro; IPR023409; 14-3-3_CS. DR InterPro; IPR036815; 14-3-3_dom_sf. DR InterPro; IPR023410; 14-3-3_domain. DR PANTHER; PTHR18860; 14-3-3 PROTEIN; 1. DR Pfam; PF00244; 14-3-3; 1. DR PIRSF; PIRSF000868; 14-3-3; 1. DR PRINTS; PR00305; 1433ZETA. DR SMART; SM00101; 14_3_3; 1. DR SUPFAM; SSF48445; 14-3-3 protein; 1. DR PROSITE; PS00796; 1433_1; 1. DR PROSITE; PS00797; 1433_2; 1. DR PDBsum; 1A37; -. DR PDBsum; 1A38; -. DR PDBsum; 1A4O; -. DR PDBsum; 2V7D; -. PE 1: Evidence at protein level; KW 3D-structure; Acetylation; Cytoplasm; Direct protein sequencing; KW Phosphoprotein; Reference proteome. FT CHAIN 1..245 FT /note="14-3-3 protein zeta/delta" FT /id="PRO_0000058626" FT SITE 56 FT /note="Interaction with phosphoserine on interacting FT protein" FT /evidence="ECO:0000269|PubMed:18550856, FT ECO:0000269|PubMed:9632691" FT SITE 127 FT /note="Interaction with phosphoserine on interacting FT protein" FT /evidence="ECO:0000269|PubMed:18550856, FT ECO:0000269|PubMed:9632691" FT MOD_RES 1 FT /note="N-acetylmethionine" FT /evidence="ECO:0000250|UniProtKB:P63104" FT MOD_RES 3 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P63104" FT MOD_RES 58 FT /note="Phosphoserine; by PKA" FT /evidence="ECO:0000250|UniProtKB:P63104" FT MOD_RES 68 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P63104" FT MOD_RES 184 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P63104" FT MOD_RES 207 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P63104" FT MOD_RES 210 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P63102" FT MOD_RES 232 FT /note="Phosphothreonine; by CK1" FT /evidence="ECO:0000250|UniProtKB:P63104" FT CONFLICT 25 FT /note="C -> A (in Ref. 1; AA sequence)" FT /evidence="ECO:0000305" FT HELIX 3..15 FT /evidence="ECO:0007829|PDB:2V7D" FT HELIX 19..30 FT /evidence="ECO:0007829|PDB:2V7D" FT TURN 31..33 FT /evidence="ECO:0007829|PDB:1A38" FT HELIX 35..37 FT /evidence="ECO:0007829|PDB:2V7D" FT HELIX 38..67 FT /evidence="ECO:0007829|PDB:2V7D" FT HELIX 74..99 FT /evidence="ECO:0007829|PDB:2V7D" FT HELIX 100..105 FT /evidence="ECO:0007829|PDB:2V7D" FT HELIX 106..108 FT /evidence="ECO:0007829|PDB:1A38" FT HELIX 112..115 FT /evidence="ECO:0007829|PDB:2V7D" FT HELIX 117..131 FT /evidence="ECO:0007829|PDB:2V7D" FT HELIX 137..156 FT /evidence="ECO:0007829|PDB:2V7D" FT TURN 157..159 FT /evidence="ECO:0007829|PDB:2V7D" FT HELIX 165..176 FT /evidence="ECO:0007829|PDB:2V7D" FT HELIX 177..181 FT /evidence="ECO:0007829|PDB:2V7D" FT HELIX 185..201 FT /evidence="ECO:0007829|PDB:2V7D" FT TURN 202..205 FT /evidence="ECO:0007829|PDB:2V7D" FT TURN 208..210 FT /evidence="ECO:0007829|PDB:2V7D" FT HELIX 211..226 FT /evidence="ECO:0007829|PDB:2V7D" SQ SEQUENCE 245 AA; 27745 MW; D464DF2286BBFE60 CRC64; MDKNELVQKA KLAEQAERYD DMAACMKSVT EQGAELSNEE RNLLSVAYKN VVGARRSSWR VVSSIEQKTE GAEKKQQMAR EYREKIETEL RDICNDVLSL LEKFLIPNAS QAESKVFYLK MKGDYYRYLA EVAAGDDKKG IVDQSQQAYQ EAFEISKKEM QPTHPIRLGL ALNFSVFYYE ILNSPEKACS LAKTAFDEAI AELDTLSEES YKDSTLIMQL LRDNLTLWTS DTQGDEAEAG EGGEN //